002872SZSE

ST Tian Sheng Co., Ltd.

ST天圣

002872

Shenzhen Stock Exchange

Follow
31 announcements tracked· Last: May 22, 2026

Key Financials

As of 2026-05-23T00:00:00.000+00:00
Revenue¥132.0M
Net Profit-¥9.8M
ROE-0.50%
Debt Ratio25.31%
Monetary Funds¥266.1M
Receivables¥103.1M
Total Shares318.0M

Announcements

30 total

Legal Opinion from Beijing Zhongyin Law Firm on the 2025 Annual Shareholders' Meeting of Tiens Pharmaceutical Group Co., Ltd.

Share PledgeShareholding Change DisclosureListed Company Announcements

Announcement of the 2025 Annual Shareholders' Meeting Resolutions

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Progress Announcement on Other Risk Warnings Related to Stock Trading

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on Holding the 2025 Online Performance Briefing

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on Some Products Intended to Be Selected for the National Traditional Chinese Medicine Procurement Alliance Centralized Bulk Purchase

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Special Report on Correction of Prior Period Accounting Errors

Share Repurchase PlanShareholding Change DisclosureListed Company Announcements

2019 Annual Report (Corrected)

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

2017 Annual Report (Corrected)

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

2018 Annual Report (Corrected)

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

2020 Annual Report (After Correction)

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

Summary of the 2018 Annual Report (After Correction)

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

Summary of the 2017 Annual Report (After Correction)

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

Summary of the 2019 Annual Report (After Correction)

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

Summary of the 2020 Annual Report (After Correction)

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

Announcement on the Correction of Prior Accounting Errors and Retrospective Adjustments

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Audit Report on the Elimination of Issues Related to the Reserved Opinion in the 2024 Annual Report of Tiansheng Pharmaceutical Group Co., Ltd.

Share PledgeShareholding Change DisclosureListed Company Announcements

Verification Opinion of Huaxi Securities Co., Ltd. on the Storage and Use of Raised Funds of Tiansheng Pharmaceutical Group Co., Ltd. in 2025

Share PledgeShareholding Change DisclosureListed Company Announcements

Special Audit Explanation on Non-Operating Fund Occupation and Repayment Situation of Major Shareholder of Tiansheng Pharmaceutical Group Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Renewal of the Company's Audit Institution for 2026

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

2025 Annual Board Work Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Board's Special Explanation on the Elimination of Issues Related to the Reserved Opinion in the 2024 Audit Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Audit Committee's Opinion on the Special Explanation Regarding the Elimination of Issues Related to the Reserved Opinion in the 2024 Audit Report

Share Repurchase PlanShareholding Change DisclosureListed Company Announcements

Announcement on the 2026 Annual Compensation Plan for Directors and Senior Executives

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Independent Director Work Report (Yi Runzhong)

Convertible BondsShareholding Change DisclosureListed Company Announcements

Independent Director Work Report (Li Dingqing)

Convertible BondsShareholding Change DisclosureListed Company Announcements

Independent Director Work Report (Yang Dajian)

Convertible BondsShareholding Change DisclosureListed Company Announcements

Internal Control Audit Report

Share PledgeShareholding Change DisclosureListed Company Announcements

2025 Annual Internal Control Evaluation Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Articles of Association (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Compensation Management System for Directors and Senior Executives

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Notes & Comments

Sign in to leave a comment or private note.

Loading…